IGF1 and type 2 diabetes mellitus: Emerging pathophysiology models delineate sex-dimorphic metabolic dysregulation via SHS-triggered LXRα/IGF-1 axis perturbations, synergistically driving T2DM progression through lipid-glucose homeostasis disruption (14, 18).